Ministry
of Health and Family Welfare
Less than 1000 deaths recorded for 8 consecutive days
Five top States with maximum caseload contribute more than half of Total
Recoveries
Posted
On: 11 OCT 2020 11:35AM by PIB
With a very high number of COVID patients recovering every
day,
Enhanced countrywide medical infrastructure, implementation
of the Centre’s Standard Treatment Protocol by the States/UTs, and total
dedication & commitment of doctors, paramedics and frontline workers have
led to a consistent slide in the number of daily fatalities and a persistent
increase in the number of total recoveries.
For the last eight consecutive days, new deaths recorded
are less than 1000. 918 deaths were recorded in last 24 hours in the country.
The total active cases in
The national Recovery Rate has further increased to 86.17%.
With increasing recoveries,
The five top States with the maximum caseload (61% of
the Active Cases) are also contributing more than half (54.3%) of the Total
Recoveries.
80% of the new
recovered cases are being reported from ten States, viz. Maharashtra,
Karnataka, Kerala, Andhra Pradesh, Tamil Nadu, Uttar Pradesh, Odisha, West
Bengal,
74,383 new confirmed cases have been reported in the last 24 hours in the country.
80% of the new cases are
concentrated in ten States/UT. Kerala has reported the maximum number of new
cases, followed by
918 fatalities have
been registered in the past 24 hours. 84% of these are reported from 10 States and UTs.
With 308 deaths,
****
MV/SJ
HFW/COVID States data/11 October2020/1
(Release ID: 1663480) Visitor Counter : 109
Ministry
of Health and Family Welfare
Dr Harsh Vardhan shares his
Personal Cell Number to alleviate problems of his constituents during Sunday
Samvaad-5
“No religion or God says that you have to celebrate a festival in an
ostentatious way”
“Fighting against COVID is our foremost Dharma”
“Emergency Use Authorization for COVID vaccine will depend on clinical trial
data generated”
“Rollout of FELUDA Test expected in the next few weeks”
“Occupational Hazard and the Risk of Exposure to Infection primarily to
determine Vaccination Priority”
“Open to Assessing the Feasibility of Introducing several COVID-19 vaccines in
the country as per their availability”
“ICMR study to understand the True Burden of re-infected cases”
“AYUSH remedies for COVID have proven immuno-modulatory, anti-viral,
antipyretic and anti-inflammatory properties”
Posted
On: 11 OCT 2020 2:32PM by PIB
Dr. Harsh Vardhan, Union Minister of Health and Family
Welfare responded to a volley of questions fielded by his social media
interactors on the fifth episode of Sunday Samvaad. Sternly squashing rumours and removing
popular misconceptions regarding COVID, the Health Minister gave detailed
information on the role of Ayurveda in the fight against COVID, ICMR’s upcoming
study on cases of reinfection, the selection criteria for vaccination and other
critical information regarding the much touted COVID Vaccine.Upon learning on
the various difficulties faced by his constituents in Chandni Chowk, Delhi he
shared his contact details in the public platform as a response and assured
that all issues faced by people in his constituency would be resolved on
priority.
Warning people to stay away from large congregations and
diligently follow the guidelines issued by the government regarding precautions
to be taken, Dr. Harsh Vardhan requested people to celebrate upcoming festivals
at home, with their loved ones, instead of going out to fairs and pandals.
Reminding people that fighting against COVID is the foremost Dharma, he
explained that his Dharma as the Health Minister of the country is to mitigate
the virus and prevent deaths at any cost. “The Bhagwad Gita condones war for
the warrior class. So, there is no need to congregate in large numbers to prove
your faith or your religion. If we do this, we may be heading for big trouble.
Lord Krishna says concentrate on your goal..my goal and your goal .. OUR goal
is to finish this virus and save humanity. This is our religion. The religion
of the whole world.”
He added that “Extraordinary circumstances must draw
extraordinary responses. No religion or God says that you have to celebrate in
an ostentatious way, that you have to visit pandals and temples and mosques to
pray”. He exhorted citizens to join the Prime Minister Shri Narendra Modi ji’s
clarion call to take a pledge and join the massive country-wide awareness
campaign and “Jan Andolan” during the two months (including the winter season)
so that the pandemic does not spread further. Dr Harsh Vardhan shared the
possibility of increased novel coronavirus transmission during winters as it is
a respiratory virus and the transmission of respiratory viruses is known to
increase during the colder weather. “These viruses are known to thrive better
in the cold weather and low humidity conditions. In view of these, it would not
be wrong to assume that the winter season may see increased rates of
transmission of the novel coronavirus in the Indian context too,” he noted.
Adhering to the Covid appropriate behaviours of wearing masks/face covers,
especially when in public places, regularly washing of hands and maintaining of
respiratory etiquette ill help us to contain the spread of the diseases, he
reiterated firmly.
Dr. Harsh Vardhan shared the good news of the rollout of
the FELUDA Test in the near future. Based on tests in over 2000 patients during
the trials at the
On the issue of how the government plans to roll out the
COVID-19 vaccine by prioritizing target groups in the entire population, he
clarified that it is anticipated that supplies of COVID-19 vaccines would be
available in limited quantities in the beginning. He said “In a huge country
like
Reiterating that the most important component of the
planning is the cold chain and other logistics which need to be planned
appropriately to ensure no glitches occur in vaccine delivery even at the last
mile, Dr Harsh Vardhan highlighted the need of the massive advocacy required
for building community sensitization activities to understand the reasons for
vaccine hesitancy and address them appropriately. Categorically denying the
rumours of the Government prioritizing young and working-class for the COVID-19
vaccine for economic reasons, Dr Harsh Vardhan said, “the prioritisation of
groups for COVID-19 vaccine shall be based on two key considerations:
Occupational hazard and risk of exposure to infection, and the risk of
developing severe disease and increased mortality.”
Putting on his doctor hat, he explained to a respondent
that the Phase I trials are done primarily to establish the safety of the
product; Phase II Trials measure immunogenicity as a primary endpoint and
safety as a secondary endpoint; In Phase III clinical trials, both safety and
immunogenicity continue to be measured as secondary endpoints; efficacy being
the primary endpoint for this phase of a clinical trial.
On the issue of Emergency Use Authorization of COVID
vaccines in
He informed that COVID-19 Vaccines currently in trial
in
On the need to include other novel candidates as COVID
Vaccine, he said, “Considering the large population size of
The Minister requested people to not share any content
related to health & safety without double-checking its veracity. He added
that as we learn more about the novel coronavirus and more vaccine candidates
start their Phase II and Phase III Trials, there is bound to be a lot of fake
and incorrect news on social media that is perpetrated by people with vested
interests. He shared that the COVID-19 Fact Check Unit in the Press Information
Bureau (PIB) under Union Ministry of Information & Broadcasting is
regularly scanning social media platforms for fake news and requested his
followers to report such fake news to PIB‟s fact check unit.
On the matter of cases of reinfection, Dr Harsh Vardhan
stated that though there are sporadic reports of reinfection surfacing in
various states, careful analysis of ICMR database reveals that many of these
cases have actually been misclassified as reinfections. He added that it is
very important to differentiate mislabeled reinfection from actual reinfection.
“Actual reinfection would mean a fully recovered person getting infected by a
freshly introduced virus in his/her body, belonging to the same or different
strain. ICMR is commissioning a study to understand the true burden of
re-infected cases. Results will be shared in a couple of weeks”, he said.
Expressing personal trauma at the loss of doctors to the
pandemic, Dr Harsh Vardhan detailed steps taken to prevent occurrences of
COVID-19 infection among healthcare workers. States are thoroughly supported in
terms of PPE Kits, N-95 masks and HCQ for the protection and prophylaxis of
healthcare workers managing COVID cases. AIIMS,
The Minister also informed that he keeps talking personally
to all State health ministers and other health officials to ensure that our
corona warriors are well taken care of.
Responding to calls for medical attention to people in
isolation, Dr. Harsh Vardhan noted with satisfaction the sharp increase in
acceptance of telemedicine services in
During the Sunday Samvaad conversation, Dr Harsh Vardhan
shared that in the first phase the Government of India has released Rs 3000
Crores to States and UTs to battle COVID-19 pandemic. Almost all, except three
States/UTs, have utilized the complete grant given to them: Maharashtra has
only used 42.5% of the grant followed by
Answering the criticism surrounding the efficacy of AYUSH
formulations in the treatment of COVID-19, Dr Harsh Vardhan explained the
concept of Salutogenesis and how these formulations target holistic recovery of patients.
Pointing to in-depth study of literature and scientific evidence generated
from in silico studies, experimental studies, and clinical studies, he
said, “Guduchi, Ashwagandha, Guduchi & Pippali combination and AYUSH 64
have a substantial number of studies which prove their immuno-modulatory,
anti-viral, antipyretic and anti-inflammatory properties. These interventions
have also shown a good binding affinity with COVID-19 virus in in-silico
studies.” He further informed that scientific studies have been initiated
with the aforesaid remedies to assess their impact in the prophylaxis,
secondary prevention and management of COVID-19 afflicted cases on the
recommendations of the Interdisciplinary Task Force set up by the Government.
Recounting the benefits of Chyawanprash, Dr Harsh Vardhan stated that the information available through clinical studies have shown that individuals who consume Chyawanprash regularly for a definite period of time show improvement in overall health status and immunity and while sugar is an essential component, customers can opt for sugar-free versions in the market.
****
MV
HFW/ HFM 5thSunday
Samvaad/11October2020/2
(Release ID: 1663506) Visitor Counter : 121
No comments:
Post a Comment